In cluster 1/2, the incidence of FLG, BIRC6, and IGSF10 mutations were significantly higher, and it is reported that FLG contributes to the biological activity of barrier function and associates with the poor prognosis of cervical cancer [68]. This evidence concerns the gene BIRC6 and cervical cancer.